Erratum to: Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration.

Rosengren, Sanna; Dychter, Samuel S; Printz, Marie A; Huang, Lei; Schiff, Richard I; Schwarz, Hans-Peter; McVey, John K; Drake, Fred H; Maneval, Dan C; Kennard, Don A; Frost, Gregory I; Sugarman, Barry J; Muchmore, Douglas B.

Afiliação

Rosengren S; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA. srosengren@halozyme.com.
Dychter SS; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.
Printz MA; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.
Huang L; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.
Schiff RI; Baxter Bioscience, Deerfield, Illinois, USA.
Schwarz HP; Baxter Bioscience, Vienna, Austria.
McVey JK; Baxter Healthcare Corporation, Deerfield, Illinois, USA.
Drake FH; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.
Maneval DC; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.
Kennard DA; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.
Frost GI; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.
Sugarman BJ; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.
Muchmore DB; Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, California, 92121, USA.

AAPS J ; 17(6): 1523-4, 2015 Nov.

Article em En | MEDLINE | ID: mdl-26340861

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article